A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...
Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on w ...
Tired of eye strain and blurry vision? How can you keep your eyes healthy naturally? Follow these simple, science-backed eye ...
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
5d
CNET on MSNProtect Your Eyes: 10 Simple Hacks for Better VisionThe World Health Organization reports that around 2.2 billion people struggle with vision problems such as near-sightedness ...
Investing.com -- Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ: EYPT) fell 21% today, diverging from the company's recent announcement of positive results from the Phase 2 VERONA clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results